1-Methylpiperazine → HCID 178418611, compound

HRID 1734265Notes

Reaction equation

HRID 1734265 reaction equation
CO[C:3]([C:5]1[CH:10]=[C:9]([OH:11])[C:8]([O:12][CH2:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[CH:7][N:6]=1)=[O:4].[CH3:20][N:21]1[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]1>C(Cl)(Cl)Cl.CO>[CH3:20][N:21]1[CH2:26][CH2:25][N:24]([C:3]([C:5]2[CH:10]=[C:9]([OH:11])[C:8]([O:12][CH2:13][C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=3)=[CH:7][N:6]=2)=[O:4])[CH2:23][CH2:22]1

Participants

5

Conditions

Temperature
100 °C

Procedure

To a suspension of 2-methoxycarbonyl-4-hydroxy-5-benzyloxypyridine (18.15 g) in N-methylpiperazine (21.04 g) was heated to 100° C. for 3.5 hours. The resulting viscous solution was cooled to room temperature, diluted with a mixture of chloroform (270 ml) and methanol (30 ml) and subjected to column chromatography on silica gel (800 g). The eluate was evaporated in vacuo and the residue was purified by column chromatography on silica gel (600 g). The pure fractions were evaporated in vacuo and the residue was pulverized with diisopropyl ether to give 1-methyl-4-(4-hydroxy-5-benzyloxy-2-pyridylcarbonyl) piperazine (3.99 g).

Workup

  1. temperatureThe resulting viscous solution was cooled to room temperature
  2. customThe eluate was evaporated in vacuo
  3. customthe residue was purified by column chromatography on silica gel (600 g)
  4. customThe pure fractions were evaporated in vacuo

Sources & evidence

ORD record
ord-48bcb46c084546c18ec1b1ea95f2d6b4
Source dataset
uspto-grants-1996_07
Patent number
US05532354

Reaction notes

Loading…